SCHEMBL6209519

SCHEMBL6209519

Cc1ccc(COCCNC(=O)OC(C)(C)C)cc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.49
MAPT P10636 1/20 0.49
IDO1 P14902 1/20 0.48
PPARA Q07869 3/20 0.46
CA1 P00915 5/20 0.46
CA2 P00918 5/20 0.46
CA12 O43570 3/20 0.46
CA9 Q16790 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
LMNA P02545 1/20 0.46
PPARG P37231 2/20 0.44
CCNC P24863 1/20 0.42
CDK8 P49336 1/20 0.42
HTT P42858 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
GAA P10253 1/20 0.41
CTSS P25774 1/20 0.41
SYK P43405 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27308985 0.89 MAPT (0.49) TDP1MAPTIDO1PPARACA1
SCHEMBL31307121 0.89 IDO1 (0.48) TDP1IDO1PPARACA1CA2
SCHEMBL25301986 0.87 IDO1 (0.47) IDO1PPARACA1CA2CA12
SCHEMBL31307122 0.87 IDO1 (0.47) TDP1IDO1PPARACA1CA2
SCHEMBL24812942 0.87 IDO1 (0.47) TDP1IDO1PPARACA1CA2
SCHEMBL27306067 0.87 IDO1 (0.47) TDP1IDO1PPARACA1CA2
SCHEMBL506649 0.87 IDO1 (0.62) MAPTIDO1PPARACA1CA2
SCHEMBL31307120 0.83 IDO1 (0.44) TDP1MAPTIDO1PPARACA1
SCHEMBL25123221 0.82 CYP17A1 (0.47) IDO1PPARACA1CA2CA12
SCHEMBL30316999 0.82 SMN1; SMN2 (0.59) MAPTIDO1PPARACA1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0709375-B1 Therapeutic heterocycles ASTRAZENECA AB (SE) 2005-05-18 EP disclosed
US-6147083-A NOVEL SUBSTITUTED 1,2-ETHANEDIAMINE DERIVATIVES WHICH ANTAGONIZE THE PHARMACOLOGICAL ACTIONS OF THE ENDOGENOUS NEUROPEPTIDE TACHYKININS KNOWN AS NEUROKININS, USEFUL FOR THE TREATMENT OF ASTHMA, ETC. ZENECA LIMITED (GB) 2000-11-14 US disclosed
US-5998444-A ANTIASTHMA AGENTS; NEUROKININ ANTAGONIST ZENECA LTD. (GB) 1999-12-07 US disclosed
US-5710169-A NEUROKININ ANTAGONISTS; ANTIHISTAMINES, BRONCHODILATOR AGENTS; ASTHMA ZENECA LIMITED (GB) 1998-01-20 US disclosed
EP-0709375-A2 Therapeutic heterocycles ZENECA LIMITED (GB) 1996-05-01 EP disclosed